Change in the management at Eckert & Ziegler BEBIG
(Thomson Reuters ONE) -
Seneffe, Belgium, January 4, 2012. Effective as of 1 January 2012 Abel Luzuriaga
will be appointed as Managing Director of Eckert & Ziegler BEBIG and to the
Board of Directors of the company. Together with Dr. Edgar Löffler the previous
Vice President Sales will be responsible for the daily business. He thus
replaces Dr. Gunnar Mann who will dedicate himself to other tasks in the Eckert
& Ziegler Group in future. A host of further restructurings are associated with
the change in the management board of Eckert & Ziegler BEBIG of which the Board
of Directors promises a greater power of impact for the company.
"With Mr Luzuriaga a distinguished practical expert will move into top
management, who can refer to a career of more than 20years in sales and to
successes as Managing Director in the industry", Dr. Andreas Eckert, Chairman of
the Supervisory Board, explained. "We are pleased that we were able to win him
for this task. With his international experience he will help us to develop new
markets in particular in the emerging markets."
Before his start at Eckert & Ziegler BEBIG in January 2011 as Head of Sales for
France, Italy, Spain, Great Britain and India Luzuriaga worked as Managing
Director at Theranostic Medizintechnik GmbH, the German branch of the Dutch
brachytherapy specialist Nucletron B.V. for more than ten years. From 2007 he
moreover bore the responsibility as Head of Sales for the economic area of
Europe, the Middle East and Africa at Nucletron.
He started his professional career at Asea Brown Boveri AG (Mannheim) as
commissioning engineer; he subsequently held leading positions in international
sales in several companies (Dainippon Screen GmbH, OTESA Siemens Ecuador).
"I am very excited to take over the responsibility as Managing Director of
Eckert & Ziegler BEBIG as it continues to grow into one of the global leaders in
offering complete solutions in the brachytherapy", said Abel Luzuriaga. "I look
forward, with the support of its strong team and its innovative product
development, to expanding and driving its engagement with the worldwide
radiation oncology society."
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry.
Eckert & Ziegler BEBIG's core business is the treatment of cancer using
brachytherapy, a special form of radiation therapy.
Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company
headquarters are in Belgium, with a production facility in Germany and
subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG
has a worldwide network of distributors and agents to support the international
marketing of its product line.
The company's products and equipment are intended for use by oncologists,
radiologists, urologists, and medical physicists.
Eckert & Ziegler BEBIG employs more than 150 people. The company has been listed
on the Euronext stock exchange since April 1997 (Euronext: EZBG; Reuters:
EZBG.BR; Bloomberg: EZBG:BB).
Contact
Paul-Emmanuel Goethals
Investor Relations
Tel.: +32.64.520.808
Email:ir(at)bebig.eu
Website:www.bebig.eu
Karolin Riehle
Investor Relations
Tel.: +49 30 94 10 84-0
Email: info(at)ezag.de
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE
[HUG#1575166]
Unternehmensinformation / Kurzprofil:
Datum: 04.01.2012 - 17:43 Uhr
Sprache: Deutsch
News-ID 101131
Anzahl Zeichen: 4261
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 201 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Change in the management at Eckert & Ziegler BEBIG"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
